Monitoring Daily Mobility in Children With Autism
Condition(s) studied
Investigational drug(s) / intervention(s)
placement of a wearable wrist sensor: The project integrates three complementary modules on the same participant: (A) monitoring with wearable sensors (primary objective), (B) laboratory-based gait analysis, and (C) sleep assessment using home video-EEG polysomnography (PSG). The reference wearable instrumentation follows the technical protocols established by the Politecnico di Milano, which already include the use of the AX6 device and F-Scan GO insoles among the wearable devices available within the research program.
Study summary
Children with autism spectrum disorder (ASD) often show motor abnormalities and sleep disturbances that affect behavior, learning, and family quality of life. Emerging technologies such as wearable devices and markerless systems provide accessible tools for gait and sleep assessment, with actigraphy recommended for long-term monitoring in natural settings. Evidence also suggests links between sleep problems and sensory processing differences. This project, aims to integrate these approaches in a clinical-translational framework.
Eligibility
Primary outcome measure(s)
- Feasibility and adherence to continuous use of a wearable sensor in children with autism spectrum disorder (ASD) — 7 days
This objective aims to assess the feasibility and adherence to continuous use of a wearable sensor in children with autism spectrum disorder (ASD), evaluating tolerability, compliance, and data quality in real-life conditions over a 7-day monitoring period. Feasibility is primarily defined as the proportion of participants completing the protocol with valid data, while adherence is assessed through wear time, data completeness, and caregiver-reported acceptability.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| IRCCS San Raffaele | Roma | RM | Recruiting |
More IRCCS San Raffaele Roma trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07519369 on ClinicalTrials.gov ↗ ← All trials in Italy